You need to upgrade your Flash Player
No more lame excuses for horses that must perform
HY-50 is a highly purified, sterile, pyrogen-free aqueous solution of hyaluronate sodium for treatment of carpal and fetlock joint dysfunction in horses. It is available for intravenous and intra-articular use.
• Reduce the pain associated with lameness
• Effective treatment of degenerative joint disease in horses
Efficacy of Intravenously Administered HY-50 in Experimentally Induced Lameness Model
When intra-articular medication is deemed inappropriate or where there is more than one affected joint, HY-50 may be used intravenously. The dose regime is 1 syringe of HY-50 given 3 times at weekly intervals.
• 78% recovery in carpal flexion
• 81% recovery of stride length
• 84% recovery in joint circumference
• 74% recovery in Lameness score
The above recovery percentages are all after 33 days.
(Proceedings BEVA Congress 2001 – Page 203 - Comparison of the intravenous efficacy of two commercial preparations of sodium Hyaluronate in the CFA Equine Carpitis model - White G.W., Jordan S.M., Stites D., Jones E.W., Hamm J. and Aviad A. Oklahoma USA)
Owner/Trainer
HY-50 is a highly purified, sterile, pyrogen-free aqueous solution of hyaluronate sodium. It is the popular treatment of carpal and fetlock joint dysfunction in horses due to acute or chronic non-infectious synovitis.
Administered intravenously the recommended dose of HY-50 is 51mg of hyaluronate sodium – one syringe – once a week for three consecutive weeks. For intra-articular administration, the recommended dose of HY-50 is one syringe in small or medium sized joints by injection. More than one joint may be treated at the same time. Treatment may be repeated after one or more weeks if necessary, but should not exceed four consecutive weekly injections in the same joint.
Limited adverse reactions and no systemic effects have been observed or reported as a result of treatment with intra-articular HY-50. No local or systemic adverse reactions have been observed in experimental animals during safety and efficacy studies when HY-50 was administered intravenously.
Each method of use should be administered be a licensed equine veterinarian.
HY-50 Sodium Hyaluronate for Intra-Articular or Intravenous injection
It is essential that veterinary surgeons have HY-50 to treat the world's finest competition horses. HY-50's high molecular weight, coupled with its unique fermentation and purification processes make it an exceptional product.
Delivering the highest dose of Sodium Hyaluronate per ml of all the products currently on the market, HY-50's manufacturing method produces a highly effective and easy to use injection, free from animal proteins and therefore, presenting minimal opportunity for adverse local reaction. Indicated for the alleviation of joint inflammation and enhancement of joint function, HY-50 is presented in a pre- loaded syringe, delivering 50mg of Sodium hyaluronate per 3ml; most competitive products give just 20mg.
Excellent results in over half a million treated joints.
Veterinarian
HY-50 is a highly purified, sterile, pyrogen-free aqueous solution of hyaluronate sodium derived by a fermentation process using Streptococcus spp. and then purified to yield a product which is essentially free of protein and nucleic acids.
Each mL contains: Hyaluronate Sodium 17 mg: Sodium Chloride 7.57 mp; Sodium Phosphate Dibasic 3.78 mg; Sodium Phosphate Monobasic 0.45 mp; and Water for Injection q.s.
HY-50 is indicated for the intra-articular or intravenous treatment of carpal and fetlock joint dysfunction in horses due to acute or chronic non-infectious synovitis associated with equine osteoarthritis.
HY-50
Central Sales Ltd.
14 Regan Road, Unit #1
Brampton, Ontario
L7A 1B9
Canada
Tel: +1 800 387 2522
Fax: +1 905 840 1309